Amir Bista

Amir Bista practices at Encircle Health - HOPD in Appleton, Wisconsin.

Amir Bista's NPI, 1427466655, was assigned on July 31, 2014. Amir Bista holds Wisconsin license 67487.

Amir Bista's primary practice is Encircle Health - HOPD, at 2500 E Capitol Dr, Appleton, WI 54911.

Amir Bista's primary practice is Encircle Health - HOPD in Appleton, Wisconsin. Amir Bista is also affiliated with ThedaCare Regional Medical Center-Appleton. The medical group on file is ThedaCare Behavioral Health Walk-in Care-Neenah. Dmand AI also links Amir Bista to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Amir Bista practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Amir Bista's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Amir Bista's licenses on file in 2 states: Wisconsin and Pennsylvania.

CMS data shows 637 Medicare services from Amir Bista across 8 procedure codes in 2024, for 158 Medicare patients. Medicare paid $60,156 for them.

CMS counts 158 Medicare patients who saw Amir Bista in 2024. The largest group is 65 to 74, with 83 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.39, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Amir Bista's median patient age at 68, with 51% women.

In 2024, Amir Bista wrote 604 Medicare Part D claims for 195 patients. 82% of them were for generic drugs. CMS names the drug for 383 of them, across 16 drugs with 11 or more claims each, at $145,898 in total drug cost. In 2023, CMS named 858 claims across 31 drugs.

Amir Bista accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Amir Bista as offering telehealth.

Dmand AI links 14 papers to Amir Bista, published from 2014 to 2020. 2016 was the busiest year, with 2. The most frequent topics are SEER Program, Lung Neoplasms and Antineoplastic Agents. Amir Bista has published most often in Anticancer Res. Amir Bista's most frequent co-authors are Dipesh Uprety, MD, Yazhini Vallatharasu, MD and Binay Kumar Shah, MD.

CMS Open Payments shows 7 general payments to Amir Bista from 7 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 77% of the total. Celgene Corporation paid the most, $119.